A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia
Authors
Keywords
-
Journal
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Volume 371, Issue 3, Pages 692-702
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2019-10-03
DOI
10.1124/jpet.119.260869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus
- (2019) Susan McQuown et al. Frontiers in Molecular Neuroscience
- Phosphodiesterase 1 Bridges Glutamate Inputs with NO- and Dopamine-Induced Cyclic Nucleotide Signals in the Striatum
- (2019) Dahdjim B Betolngar et al. CEREBRAL CORTEX
- Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels of rats and mice
- (2019) Jie Chen et al. NEUROCHEMISTRY INTERNATIONAL
- Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance
- (2018) Anton Pekcec et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
- (2018) Ragy R. Girgis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A phase I, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
- (2017) Katja Boland et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties
- (2017) Brian Dyck et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a
- (2017) Jillian R. Hufgard et al. PSYCHOPHARMACOLOGY
- A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events
- (2017) Paul Goldsmith et al. Drugs in research & development
- The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets
- (2016) Manato Kotani et al. BEHAVIOURAL BRAIN RESEARCH
- Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases
- (2016) Peng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy
- (2016) Yu-Wen Li et al. NEUROPHARMACOLOGY
- Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats
- (2016) Gretchen L. Snyder et al. PSYCHOPHARMACOLOGY
- An emerging role of cGMP in the treatment of schizophrenia: A review
- (2016) Seong Shim et al. SCHIZOPHRENIA RESEARCH
- The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets
- (2015) Satoko Baba et al. BEHAVIOURAL BRAIN RESEARCH
- Modeling psychiatric disorders for developing effective treatments
- (2015) Tobias Kaiser et al. NATURE MEDICINE
- Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment
- (2014) Gretchen Snyder et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of lurasidone on executive function in common marmosets
- (2013) Takeshi Murai et al. BEHAVIOURAL BRAIN RESEARCH
- Select 3′,5′-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain
- (2013) Michy P. Kelly et al. CELLULAR SIGNALLING
- Phosphodiesterase 10A inhibitor MP-10 effects in primates: Comparison with risperidone and mechanistic implications
- (2013) Subramaniam Uthayathas et al. NEUROPHARMACOLOGY
- Discovery of Novel N-Substituted Oxindoles as Selective M1 and M4 Muscarinic Acetylcholine Receptors Partial Agonists
- (2013) Takaaki Sumiyoshi et al. ACS Medicinal Chemistry Letters
- D1 receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats
- (2012) Masakuni Horiguchi et al. BEHAVIOURAL BRAIN RESEARCH
- Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
- (2011) Gary Remington et al. Expert Review of Neurotherapeutics
- Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Biochemical and Behavioral Profiles of Phosphodiesterase Inhibition in Dopaminergic Neurotransmission
- (2010) Akinori Nishi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
- (2010) Viktor Lakics et al. NEUROPHARMACOLOGY
- Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
- (2009) S. M. Grauer et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A
- (2009) Christine A. Strick et al. NEUROPHARMACOLOGY
- Scintillation Proximity Assays in High-Throughput Screening
- (2008) J. Fraser Glickman et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
- (2008) C. J. Schmidt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
- (2008) Olga A. H. Reneerkens et al. PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now